[1]
Gisondi, P. et al. 2025. [Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]. Farmeconomia. Health economics and therapeutic pathways. 26, 1 (May 2025). DOI:https://doi.org/10.7175/fe.v26i1.1571.